Jazz Pharmaceuticals plc looks very undervalued at 2.4x sales as oncology catalysts (Ziihera, Zepzelca, Epidiolex) drive ...
There's no coming back from death, but that doesn't mean that all of you goes at the same time, some parts linger on for days ...
STAYING with a friend recently, above my bed hung what I at first took to be a piece of felted art. On touching it however I found it was a peel ...
EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...
HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the ...
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
RAAINBOW-2 is an international, double-blind, placebo-controlled Phase 3 study for the treatment of moderate to severe alopecia areata (AA) in at least 500 subjects. -- Cinainu is the first topical ...
US FDA & CDE in China grants breakthrough therapy designation to Bayer’s sevabertinib as a first-line treatment for patients with HER2-mutant NSCLC: Berlin Wednesday, January 7, ...
The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
FREDERICK, Md., Jan. 5, 2026 /PRNewswire/ -- Phycin has been selected to receive an award through the ReGen Valley Tech Hub ...
Millennial Skin on MSN
Why skin gets complicated in middle age — and what’s actually happening beneath the surface
Middle age marks a noticeable shift in how skin behaves, repairs itself, and responds to products that once worked ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best affordable stocks with good earnings growth for 2026. Halozyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback